SBI Securities »

Cue Biopharma shares owned by SBI Securities

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.5k 300 31.56

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Apple (AAPL)
Micron Technology (MU)
Vanguard Total World Stock ETF Etf (VT)
Alphabet Inc Class A cs (GOOGL)
Tesla Motors (TSLA)
Direxion Daily Semi Bull 3X ETF Etf (SOXL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Inc Class C cs (GOOG)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)

View all positions for SBI Securities

Top funds holding Cue Biopharma

Bleichroeder
Driehaus Capital Management
Vanguard Capital Management
Ikarian Capital
Polygon Management
Stempoint Capital
BlackRock
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Diadema Partners
Geode Capital Management
Belvedere Trading
Boothbay Fund Management
UBS Group

View all funds holding Cue Biopharma